Vilzemetkib CAS 1363402-44-1 MF C36H36F2N4O5 MW 642.7 g/mol 1-N‘-[4-[7-[[1-(cyclopentylamino)cyclopropyl]methoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 1,1-Cyclopropanedicarboxamide, N-[4-[[7-[[1-(cyclopentylamino)cyclopropyl]methoxy]-6-methoxy-4-quinolinyl]oxy]-3-fluorophenyl]-N’-(4-fluorophenyl)- 1-N’-[4-[7-[[1-(cyclopentylamino)cyclopropyl]methoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 1363402-44-1 N-[4-[[7-[[1-(Cyclopentylamino)cyclopropyl]methoxy]-6-methoxy-4-quinolinyl]oxy]-3-fluorophenyl]-N’-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide hepatocyte growth factor receptor inhibitor, antineoplastic, AL 2846, FJ4Y6XP24Y Vilzemetkib (also known as AL2846) is an investigational, orally active small-molecule drug that acts as a potent inhibitor of the c-Met receptor tyrosine kinase, a protein often overexpressed in cancers, aiming to block tumor growth, … Continue reading Vilzemetkib
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed